Major depressive disorder (MDD) is a highly prevalent psychiatric disorder and a major
cause of disability worldwide. This neurological condition is commonly associated with …

The drugs of abuse, methamphetamine and MDMA, produce long‐term decreases in
markers of biogenic amine neurotransmission. These decreases have been traditionally …

In this review, we focus on the relationship among Parkinson's disease (PD), stress and
depression. Parkinson's disease patients have a high risk of developing depression, and it is …

Increasing evidence has shown that abnormal metabolic phenotypes in body fluids reflect
the pathogenesis and pathophysiology of Parkinson's disease (PD). These body fluids …

Unlike many other neurodegenerative diseases with established gene–environment
interactions, Huntington's disease (HD) is viewed as a disorder governed by genetics. The …

Parkinson's disease (PD) is a progressive and multifactorial neurodegenerative disease. It
has been suggested that a dysregulation of the hypothalamic–pituitary–adrenal axis (HPA) …

Alzheimer's Disease (AD) is the most prevalent progressive neurodegenerative disease; to
date, no AD therapy has proven effective in delaying or preventing the disease course. In the …

Background Depression is considered a predictive factor for cognitive impairments. At the
same time, Parkinson's disease (PD) is a growing public health problem. The aim of this …

Prenatal stress exerts a strong impact on fetal brain development in rats impairing
adaptation to stressful conditions, subsequent vulnerability to anxiety, altered sexual …

Huntington's Disease (HD) is a progressive neurodegenerative disease caused by a
mutation in the huntingtin gene. The mutation leads to a toxic gain of function of the mutant …